Neurogene Natural History Study Still Enrolling CLN5 Patients

Neurogene Natural History Study Still Enrolling CLN5 Patients

305419

Neurogene Natural History Study Still Enrolling CLN5 Patients

A natural history study in people with CLN7 disease is now fully enrolled, but patients with CLN5 disease — each a form of late-infantile Batten disease, and both are in this study — are still needed, Neurogene, which is sponsoring the research, announced. The study (NCT03822650), underway at the University of Rochester Medical Center in New York, is still recruiting CLN5 patients of all ages, Neurogene stated in a release provided to Batten Disease News. Enrollment information is available here…

You must be logged in to read/download the full post.